Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0265 Transporter Info
Gene Name	SLC2A7
Transporter Name	Glucose transporter type 7
Gene ID	155184
UniProt ID	Q6PXP3

Post-Translational Modification of This DT
Overview of SLC2A7 Modification Sites with Functional and Structural Information
Sequence	M E N K E A G T P P P I P S R E G R L Q P T L L L A T L S A A F G S A F Q Y G Y N L S V V N T P H K V F K S F Y N E T Y F E R H A T F M D G K L M L L L W S C T V S M F P L G G L L G S L L V G L L V D S C G R K G T L L I N N I F A I I P A I L M G V S K V A K A F E L I V F S R V V L G V C A G I S Y S A L P M Y L G E L A P K N L R G M V G T M T E V F V I V G V F L A Q I F S L Q A I L G N P A G W P V L L A L T G V P A L L Q L L T L P F F P E S P R Y S L I Q K G D E A T A R Q A L R R L R G H T D M E A E L E D M R A E A R A E R A E G H L S V L H L C A L R S L R W Q L L S I I V L M A G Q Q L S G I N A I N Y Y A D T I Y T S A G V E A A H S Q Y V T V G S G V V N I V M T I T S A V L V E R L G R R H L L L A G Y G I C G S A C L V L T V V L L F Q N R V P E L S Y L G I I C V F A Y I A G H S I G P S P V P S V V R T E I F L Q S S R R A A F M V D G A V H W L T N F I I G F L F P S I Q E A I G A Y S F I I F A G I C L L T A I Y I Y V V I P E T K G K T F V E I N R I F A K R N R V K L P E E K E E T I D A G P P T A S P A K E T S F
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A7			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	57
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC2A7 Asparagine 57 has the potential to affect its expression or activity.
Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A7			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A7 Serine 54 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A7			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A7 Serine 279 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A7			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	66
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A7 Threonine 66 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A7			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A7 Threonine 503 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A7			[2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	60
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A7 Tyrosine 60 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR7_HUMAN)
2	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
3	Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties. Mol Cell Proteomics. 2016 Mar;15(3):1017-31.
4	Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence